Study guide

Chemistry QC, Interferences, Specimen Handling, and Result Correlation

ASCP MLT Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 ASCP MLT Exam Overview and Laboratory Operations

Current Exam Facts and CAT Scoring Eligibility Routes and MLT Study Strategy Laboratory Safety, Quality, and Compliance Lab Math, Instrumentation Troubleshooting, and Result Verification

2 Chemistry, Urinalysis, and Body Fluid Interpretation

Chemistry Calculations, Acid-Base, and Electrolytes Renal, Liver, Endocrine, Enzyme, TDM, and Toxicology Patterns Chemistry QC, Interferences, Specimen Handling, and Result Correlation Urinalysis Microscopy and Body Fluid Decision Patterns

3 Hematology and Hemostasis

CBC, RBC Indices, Reticulocytes, and Anemia Patterns Leukocyte Morphology, Differentials, and Disease Clues Platelet Findings, Coagulation Pathways, PT/aPTT, and Hemostasis Testing Hematology Quality Flags, Specimen Issues, and Smear Review Decisions

4 Blood Banking and Transfusion Practice

ABO/Rh Typing: Forward, Reverse, and Discrepancies Antibody Screen, Identification, DAT, Elution, and Enhancement Methods Compatibility Testing, Crossmatch, Components, and Storage Transfusion Reactions, HDFN, Donor/Product Decisions, and Safety Workflow

5 Microbiology Workups and Susceptibility Reasoning

Specimen Quality, Safety, and Culture Setup Gram Stain, Media, and Biochemical Identification Mycology, Mycobacteriology, Virology, and Parasitology Essentials Antimicrobial Susceptibility, QC, and Postanalytic Reporting

6 Immunology, Integrated Cases, and Final Review

Immunology Principles, Autoimmune Testing, Infectious Serology, and Molecular/Serologic Methods Transplant, Complement, Immunoglobulins, and Result Interpretation Integrated Case Reasoning Across Departments Final Seven-Day Review, CAT Pacing, and Remediation

Chemistry QC, Interferences, Specimen Handling, and Result Correlation

Key Takeaways Explain This Topic AI

Quality control questions test whether the run is acceptable before patient results are released.

A 1_2s control event is a warning, while 1_3s, 2_2s, R_4s, 4_1s, and 10x patterns generally require rejection or investigation under the lab's QC plan.

Hemolysis, icterus, and lipemia can interfere with chemistry methods by adding analyte, altering absorbance, or creating turbidity.

Specimen handling errors such as delayed separation, wrong anticoagulant, IV contamination, light exposure, or evaporation can mimic disease.

Result verification combines QC status, analyzer flags, specimen integrity, delta checks, critical-value policy, and clinical plausibility.

Last updated: May 2026

QC is part of chemistry interpretation

The official MLT chemistry outline repeatedly pairs test procedures with specimen collection, processing, troubleshooting, and interfering substances. That means QC is not separate from chemistry. It is the gatekeeper for whether patient chemistry results are reportable.

Westgard-style rule map

  • Rule cue What it suggests Usual response concept
  • 1_2s One control beyond +/-2 SD Warning; inspect but not automatic rejection alone
  • 1_3s One control beyond +/-3 SD Reject run and investigate
  • 2_2s Two controls or two runs beyond same +/-2 SD side Systematic error or shift
  • R_4s One control high and another low by more than 4 SD total Random error
  • 4_1s Four controls beyond same +/-1 SD side Systematic bias
  • 10x Ten consecutive controls on one side of mean Shift or bias even if values are within 2 SD

The exam usually gives a short QC story and asks for the best action or rule. First decide if QC is acceptable. If not, do not release patient results from that run until the lab's corrective process is complete.

Interference patterns

Hemolysis adds intracellular contents and can falsely increase potassium, LD, AST, and phosphorus. It can also interfere spectrally or chemically depending on the assay. Icterus can interfere with photometric methods and is especially relevant when bilirubin is high. Lipemia creates turbidity and volume displacement issues, especially for photometric assays and some indirect ion-selective electrode results.

EDTA contamination has a recognizable pattern: potassium may be very high while calcium and magnesium are unexpectedly low. IV contamination can dilute analytes or add glucose, electrolytes, or medications from the line. Delayed separation lowers glucose and can alter potassium. Light exposure can affect bilirubin. Ammonia and lactate are time-sensitive and technique-sensitive.

Result correlation workflow

Use this reporting screen before releasing an unexpected chemistry result:

QC acceptable? Check current controls, calibration status, reagent lot, maintenance, and analyzer flags.

Specimen acceptable? Review hemolysis, icterus, lipemia, clotting, insufficient volume, wrong tube, delay, and collection site.

Delta plausible? Compare with prior values when available and allowed by policy.

Pattern coherent? Ask whether related analytes move together, such as high potassium with hemolysis or high ALP with high GGT.

Policy triggered? Follow critical-value, repeat, recollect, and documentation rules.

Lot changes and calibration

A new reagent lot should not be placed into routine patient reporting without verification. Lot-to-lot comparison, QC recovery, calibration checks, and acceptable bias limits protect against systematic shifts. When multiple methods or analyzers exist, method differences can also explain deltas, so the MLT should verify the source before assuming patient change.

Practical exam cue

If an option says to report an implausible critical value without checking specimen quality or QC, it is usually unsafe. If an option says to delete the result without documentation, it is also unsafe. The better MLT answer usually follows policy: hold or verify the result, repeat if appropriate, recollect if specimen integrity is compromised, document corrective action, and notify according to critical-result procedure.